NeuroOne Medical Technologies Corporation
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | 17.9% | 17.9% | -6.3% |
| FY2017 | 100.4% | 100.4% | -2,023.5% |
| FY2019 | 547.9% | 547.9% | -1,273.2% |
| FY2020 | -660.2% | -660.2% | -286.6% |
| FY2021 | -151.8% | -151.8% | -125.3% |
| FY2022 | -104.1% | -104.1% | -78.0% |
| FY2023 | -189.8% | -189.8% | -146.5% |
| FY2024 | -1,498.5% | -1,498.5% | -229.4% |
| FY2025 | -51.0% | -51.0% | -33.4% |